申请人:Redda Kinfe Ken
公开号:US20130109716A1
公开(公告)日:2013-05-02
The compounds herein disclosed are tetrahydroisoquinoline analogs that have modifications on the phenyl rings by introducing groups with various electronic properties. These derivatives of tetrahydroisoquinoline have been shown to have anti-proliferative activity against cells. In particular, the compounds have been found to be effective in inhibiting the proliferation of cancer cells, such as cancer cells that originated in breast tissue. Additionally, it has been shown that the novel compounds have IC
50
values against the breast cancer cells that are 6-10-fold less than the IC
50
of tamoxifen.
本发明公开的化合物是四氢异喹啉类似物,通过对苯环进行改造,引入了具有各种电子性质的基团。这些四氢异喹啉衍生物显示出对细胞的抗增殖活性。特别是,这些化合物被发现对抑制癌症细胞的增殖非常有效,例如起源于乳腺组织的癌细胞。此外,实验结果表明,这些新化合物对乳腺癌细胞的半抑制浓度(IC50值)比他莫昔芬的IC50值低6-10倍。